The estimated Net Worth of John Melo is at least $4.44 Millón dollars as of 15 August 2022. Mr Melo owns over 17,155 units of Amyris Inc stock worth over $25,493 and over the last 14 years he sold AMRS stock worth over $3,069,517. In addition, he makes $1,344,913 as Pres y CEO & Director at Amyris Inc.
Mr has made over 20 trades of the Amyris Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 17,155 units of AMRS stock worth $69,135 on 15 August 2022.
The largest trade he's ever made was exercising 668,730 units of Amyris Inc stock on 31 August 2012 worth over $187,244. On average, Mr trades about 29,966 units every 73 days since 2011. As of 15 August 2022 he still owns at least 509,856 units of Amyris Inc stock.
You can see the complete history of Mr Melo stock trades at the bottom of the page.
John G. Melo is the Pres, CEO & Director at Amyris Inc.
As the Pres y CEO & Director of Amyris Inc, the total compensation of Mr Melo at Amyris Inc is $1,344,913. There are no executives at Amyris Inc getting paid more.
Mr Melo is 55, he's been the Pres y CEO & Director of Amyris Inc since . There are 12 older and 7 younger executives at Amyris Inc. The oldest executive at Amyris Inc is Patrick Yang, 72, who is the Independent Director.
John's mailing address filed with the SEC is C/O AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE, CA, 94608.
Over the last 14 years, insiders at Amyris Inc have traded over $118,642,007 worth of Amyris Inc stock and bought 100,049,915 units worth $258,812,433 . The most active insiders traders include Gas & Power Usa, Sas Total, L John Doerr y Philippe Boisseau. On average, Amyris Inc executives and independent directors trade stock every 25 days with the average trade being worth of $65,903. The most recent stock trade was executed by Hermanus Kieftenbeld on 2 June 2023, trading 20,999 units of AMRS stock currently worth $19,949.
amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. the company is delivering its no compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. more information about the company is available at www.amyris.com.
Amyris Inc executives and other stock owners filed with the SEC include: